Encode Ideas, LP

28 Old Rudnick Lane
Dover, DC
United States 19901

Encode Ideas, L.P is a health care focused research firm, founded in 2019, providing institutional quality research and actionable investment ideas to the general investing public.

Recent News

  • Encode Ideas, L.P. Announces the Initiation of Research Coverage on Processa Pharmaceuticals, Inc.

    Dover, Delaware--(Newsfile Corp. - February 22, 2021) - Encode Ideas, L.P. Initiates Research on Processa Pharmaceuticals, Inc. (NASDAQ: PCSA). The full research publication is available here and available on our website at www.encodelp.com. Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on Processa Pharmaceuticals, Inc. (NASDAQ: PCSA). The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options...

    2021-02-22 8:30 AM EST
  • Encode Ideas, L.P. Announces the Initiation of Research Coverage on Ocuphire Pharma Inc.

    Dover, Delaware--(Newsfile Corp. - November 9, 2020) - Encode Ideas, L.P. Initiates Research on Ocuphire Pharma Inc. (NASDAQ: OCUP). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on Ocuphire Pharma, Inc. (NASDAQ: OCUP). Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's lead...

    2020-11-09 9:00 AM EST
  • Encode Ideas, L.P. Announces the Initiation of Research Coverage on Perimeter Medical Imaging, AI

    Dover, Delaware--(Newsfile Corp. - October 21, 2020) - Encode Ideas, L.P. Initiates Research on Perimeter Medical Imaging, AI (TSXV: PINK) (FSE: 4PC). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P. is initiating coverage on Perimeter Medical Imaging AI, Inc. as a High Conviction Investment Idea. Perimeter's Optical Tissue Imaging System, or OTIS, is an FDA 510(k) cleared optical coherence technology (OCT) that can rapidly image large tissue surfaces,...

    2020-10-21 8:30 AM EDT
  • Encode Ideas, L.P. to Host Key Opinion Leader Conference Call with Dr. Jonathan Zager, Principal Investigator for Delcath System's Phase 3 FOCUS Study

    Dover, Delaware--(Newsfile Corp. - September 28, 2020) - Encode Ideas, L.P. announces they will be hosting a conference call with Dr. Jonathan Zager, surgical oncologist at Moffitt Cancer Center and the principal investigator for the Phase 3 FOCUS study, on Wednesday, September 30 at 3:00 pm Eastern Time. The purpose of the call will be to discuss the current metastatic ocular melanoma (mOM) treatment landscape, with a focus on the potential role that melphalan/hepatic delivery system via percutaneous hepatic...

    2020-09-28 10:50 AM EDT
  • Encode Ideas, L.P. Announces the Initiation of Research Coverage on Epigenomics AG.

    Dover, Delaware--(Newsfile Corp. - June 17, 2020) - Encode Ideas, L.P. Initiates Research on Epigenomics AG (Xetra: ECX.DE) (FSE: ECX) (OTC: EPGNF). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on Epigenomics AG as a High Conviction Investment Idea. Epigenomics has the first and only FDA-approved blood-based test, Epi proColon, for the detection of colorectal cancer. The company...

    2020-06-17 3:00 AM EDT
  • Encode Ideas, L.P. Announces the Initiation of Research Coverage on Delcath Systems, Inc.

    Dover, Delaware--(Newsfile Corp. - May 19, 2020) - Encode Ideas, L.P. Initiates Research on Delcath Systems, Inc (NASDAQ: DCTH). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas is initiating coverage on Delcath Systems (NASDAQ: DCTH) as a high conviction investment idea. Delcath is an interventional oncology company developing a liver isolating technology, known as Hepatic Delivery System (HDS), that allows for high-dose chemotherapy, to be targeted towards tumors...

    2020-05-19 8:30 AM EDT
  • Encode Ideas, L.P. Announces the Initiation of Research Coverage on TLC

    Dover, Delaware--(Newsfile Corp. - April 27, 2020) - Encode Ideas, L.P. Initiates Research on TLC (NASDAQ: TLC) (TWO: 4152). The full research publication is available here and available on our website at www.encodelp.com. A summary follows:Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on TLC (NASDAQ: TLC) (TWO: 4152) as a high conviction idea. TLC is a leading drug delivery/reformulation company with two late-stage assets focused on pain, and earlier stage assets for oncology...

    2020-04-27 8:30 AM EDT
  • Encode Ideas, L.P. Announces the Initiation of Research Coverage on Acasti Pharma, Inc.

    Dover, Delaware--(Newsfile Corp. - November 25, 2019) - Encode Ideas, L.P. Initiates Research on Acasti Pharma, Inc. (NASDAQ: ACST). The full research publication is available here and available on our website at www.encodelp.com. Encode Ideas is initiating coverage on Acasti Pharma, Inc. as a high-risk investment idea. Acasti is developing a krill-based omega-3 fatty acid product, CaPre, for the treatment of severe hypertriglyceridemia. Acasti is currently conducting two virtually identical Ph3 studies - Trilogy I and Trilogy II- with...

    2019-11-25 8:30 AM EST